EO 14398 - purchase of development of a human neural network formation new approach method for the evaluation of potential developmental neurotoxicity

Ended Purchase Order Awarded Last action

Contract number
75F40126P00176
Awardee
Awarding agency
Obligated
$70,500

Award facts

Opportunity
  • 75F40126Q00291 Solicitation number
Contract value 100% obligated
$70,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Framingham, MA 01702, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Terminate for Convenience P00001 · The purpose of this modification is to terminate of the contract for convenience of the government. $0
Original award $70,500

About this award

The Food and Drug Administration awarded a purchase order to Cyprotex US LLC for $70,500.00 on September 1, 2026, for development of a human neural network formation method to evaluate potential developmental neurotoxicity under Executive Order 14398. The order is effective through October 9, 2026, and carries firm fixed-price terms with no small business set-aside. Work is performed in Framingham, Massachusetts. This award was terminated for convenience of the government.

Quick answers

Who was awarded contract 75F40126P00176?

75F40126P00176 was awarded to Cyprotex US LLC by Food and Drug Administration (Department of Health and Human Services) on September 1, 2026.

How much is contract 75F40126P00176 worth?

The government has obligated $70,500 on 75F40126P00176.

Was contract 75F40126P00176 competed?

The extent of competition for 75F40126P00176 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award